MAP3K13 anticorps (AA 711-810)

N° du produit ABIN522632

Détail du produit anti-MAP3K13 anticorps

Antigène: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Épitope: AA 711-810

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp MAP3K13 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Fonction: Mouse monoclonal antibody raised against a partial recombinant MAP3K13.

Séquence: SEPDKGQAGP WGCCQADAYD PCLQCRPEQY GSLDIPSAEP VGRSPDLSKS PAHNPLLENA QSSEKTEENE FSGCRSESSL GTSHLGTPPA LPRKTRPLQK

Réactivité croisée: Humain

Attributs du produit: Antibody Reactive Against Recombinant Protein.

Immunogène: MAP3K13 (NP_004712.1, 711 a.a. ~ 810 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Clone: 4H7

Isotype: IgG2a

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: In 1x PBS, pH 7.4

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Détails sur MAP3K13

Antigène: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Autre désignation: MAP3K13 (MAP3K13 Produits)

Synonymes: anticorps LZK, anticorps MEKK13, anticorps MLK, anticorps C130026N12Rik, anticorps lzk, anticorps map3k13, anticorps map3k13a, anticorps mekk13, anticorps map3k13-a, anticorps map3k13-b, anticorps map3k13b, anticorps mitogen-activated protein kinase kinase kinase 13, anticorps mitogen-activated protein kinase kinase kinase 13 L homeolog, anticorps mitogen-activated protein kinase kinase kinase 13 S homeolog, anticorps MAP3K13, anticorps Map3k13, anticorps map3k13.L, anticorps map3k13, anticorps map3k13.S

Sujet: Full Gene Name: mitogen-activated protein kinase kinase kinase 13
Synonyms: LZK,MGC133196

ID gène: 9175

NCBI Accession: NM_004721

Pathways: Signaling Events mediated by VEGFR1 and VEGFR2